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Abstract
Background: The myelin sheath is a multilamellar membrane structure wrapped around the axon,
enabling the saltatory conduction of nerve impulses in vertebrates. Myelin basic protein, one of the
most abundant myelin-specific proteins, is an intrinsically disordered protein that has been shown
to bind calmodulin. In this study, we focus on a 19-mer synthetic peptide from the predicted
calmodulin-binding segment near the C-terminus of human myelin basic protein.
Results: The interaction of native human myelin basic protein with calmodulin was confirmed by
affinity chromatography. The binding of the myelin basic protein peptide to calmodulin was tested
with isothermal titration calorimetry (ITC) in different temperatures, and Kd was observed to be
in the low µM range, as previously observed for full-length myelin basic protein. Surface plasmon
resonance showed that the peptide bound to calmodulin, and binding was accompanied by a
conformational change; furthermore, gel filtration chromatography indicated a decrease in the
hydrodynamic radius of calmodulin in the presence of the peptide. NMR spectroscopy was used to
map the binding area to reside mainly within the hydrophobic pocket of the C-terminal lobe of
calmodulin. The solution structure obtained by small-angle X-ray scattering indicates binding of the
myelin basic protein peptide into the interlobal groove of calmodulin, while calmodulin remains in
an extended conformation.
Conclusion: Taken together, our results give a detailed structural insight into the interaction of
calmodulin with a C-terminal segment of a major myelin protein, the myelin basic protein. The used
19-mer peptide interacts mainly with the C-terminal lobe of calmodulin, and a conformational
change accompanies binding, suggesting a novel mode of calmodulin-target protein interaction.
Calmodulin does not collapse and wrap around the peptide tightly; instead, it remains in an
extended conformation in the solution structure. The observed affinity can be physiologically
relevant, given the high abundance of both binding partners in the nervous system.
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Background
The myelin sheath is a tightly packed multilamellar mem-
brane structure crucial for the correct functioning of the
vertebrate nervous system. Myelin carries a specific set of
proteins, whose expression is tightly regulated during
development. Biochemically, the composition of myelin
in the central and peripheral nervous system (CNS and
PNS, respectively) is different from each other [1]. Muta-
tions in myelin proteins or an autoimmune attack
towards them can lead to devastating neurological dis-
eases.
One of the most abundant proteins of myelin is the mye-
lin basic protein (MBP) [2,3]. MBP is a protein family, of
which the 18.5-kDa isoform predominates in adult mye-
lin [2,4]. In CNS myelin, it comprises 30% of the total
protein; it is also present in PNS myelin [5]. MBP is
thought to be involved in the tight association of the cyto-
plasmic leaflets of apposing myelin membranes within
compact myelin, where there is little, if any, cytoplasm
present [6]. Several segments of MBP are target autoanti-
gens that have been characterised in multiple sclerosis [7].
A bewildering amount of post-translational modifica-
tions, in addition to extensive alternative splicing, have
been observed for MBP, leading to a number of size and
charge isoforms [2]. MBP has also been characterised as
being intrinsically unstructured, with a possibility of local
folding, especially upon binding to ligands [3]. A low-res-
olution 3-dimensional model for MBP adsorbed to a lipid
monolayer has been built based on electron microscopy
[8,9]. Solution scattering experiments have also indicated
an unfolded structure for lipid-free MBP; in the lipid-
bound state, however, the protein seems compact but not
globular [10].
Several interaction partners for MBP have been character-
ised, including actin [11-13], tubulin [14,15], and cal-
modulin (CaM) [11,16-23]. Although the interaction
between MBP and CaM was initially reported already in
1980 [17], relatively little structural information is availa-
ble about the interaction [22]. In addition, MBP seems to
have multiple regions capable of binding CaM [21,22],
and it is not fully clear which of the CaM-binding sites are
of physiological relevance. Some assays have also indi-
cated a heterogeneous mode for the interaction [20,21],
and the interaction is affected by MBP post-translational
modifications, such as citrullination [20-22,24]. The main
CaM-binding site has been suggested to reside in the C-
terminal region of CaM, between residues 132–167
[20,21]. At least one more site lies in the central/N-termi-
nal region of MBP [20-22].
In the present study, we have used a synthetic peptide
from the predicted CaM-binding segment near the C-ter-
minus of human MBP to study the MBP-CaM interaction.
We have used a number of biochemical and biophysical
methods to confirm the interaction, thus accurately map-
ping the binding site of the peptide in CaM, and to obtain
thermodynamic and structural data regarding complex
formation in solution.
Results
Native human brain MBP binds to CaM
Affinity chromatography on CaM-sepharose was used to
investigate the binding of human brain native MBP by
CaM. The results clearly indicated that in the presence of
calcium ions, MBP is retained in the affinity matrix, and
that upon complexation of calcium by using EGTA, MBP
is released (Figure 1A). Thus, the interaction is calcium-
dependent, as earlier shown for bovine, murine, and
human brain MBP [17-20]. Mass spectroscopic analysis
indicated that the main human adult MBP isoforms, 17.2
and 18.5 kDa, were both present in the EGTA eluate, indi-
cating that neither one of them is deficient in binding
CaM (Additional file 1). Both in gel electrophoresis and
mass spectroscopy, the 18.5-kDa isoform was more abun-
dant.
Selection of a putative CaM-binding peptide
Previously, a region near the C-terminus of MBP has been
suggested to be its major CaM-binding site [20,21]. We
used a number of sequence analysis methods to select a
peptide from this region that would be expected to bind
CaM with high affinity. A combination of the following
parameters was used: predicted propensity to fold into a
helix, a low score in disorder predictions, the presence of
a putative CaM-binding site according to the CaM target
database [25], and detectable sequence homology to
other well-characterised CaM targets. In addition, a search
for putative functionally flexible regions was carried out
using Wiggle. The results of these analyses are shown in
Figure 1.
The peptide HKGFKGVDAQGTLSKIFKL, corresponding
to residues 138–156 of human 18.5-kDa MBP, was
selected for the experiments. In brief, this is one of the two
regions recognised as putative CaM targets by the CaM tar-
get database, and clearly one of the few regions in MBP
that are consistently not predicted to be disordered by var-
ious disorder prediction algorithms. It is also predicted to
be able to fold into an α-helix.
Conformational analysis by circular dichroism 
spectroscopy
Circular dichroism (CD) experiments were performed to
compare the secondary structure, folding, and thermal
stability of CaM in the presence and absence of the MBP
peptide. The CD spectrum of CaM alone showed a shape
typical of α-helical proteins, with negative minima at 206BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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and 221 nm and a positive maximum at 196 nm (Figure
2A). The CD spectrum of the complex was only slightly
different from the spectrum of CaM, indicating that no
major conformational changes take place upon complex
formation. The k2d program [26] was used to predict the
secondary structure contents (Table 1). The proportional
content of α-helix was somewhat smaller in the complex
than in CaM, reflecting the observation that the peptide in
the absence of CaM contained no α-helix under the
employed conditions (Table 1). While the fitting method
Interaction between human brain MBP and CaM and selection of the peptide for the CaM interaction study Figure 1
Interaction between human brain MBP and CaM and selection of the peptide for the CaM interaction study. A. 
Electrophoretic analysis by SDS-PAGE of the fractions from affinity chromatography of human brain MBP on CaM-sepharose. 
The samples are as follows: 1, adult human brain MBP isoforms loaded into the column; 2–6, washes with a buffer containing 50 
mM HEPES pH 7.5, 150 mM NaCl, and 2 mM CaCl2; 7–11, elution with a buffer containing 50 mM HEPES pH 7.5, 150 mM 
NaCl, and 2 mM EGTA. The observed strong protein band corresponds to the 18.5-kDa main human MBP isoform. The pres-
ence of also the 17.2-kDa isoform in both the second wash (lane 3) and the second EGTA eluate (lane 8) was confirmed by 
mass spectrometry (see Additional file 1). B. The sequence of human 18.5-kDa MBP, in which the bold, boxed region is the 
peptide eventually selected. Below the sequence, various results from sequence analysis are shown: NPSA secondary structure 
prediction, black arrows (helix) and cylinders (strand); DISembl disorder prediction using the 3 different learning sets in the 
program, blue-red-green; Wiggle prediction for functionally flexible regions, magenta; GlobPlot prediction of disorder, orange; 
suggested CaM-binding sites according to the CaM target database, yellow; DRIP-PRED disorder prediction, black. C. Manual 
alignment of the selected peptide with CaM-binding segments from three human CaM-dependent protein kinases. The posi-
tions of the conserved hydrophobic anchor residues in CaM-dependent kinases are indicated below the alignment.BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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suggests a large fraction of β-strand in the peptide in the
absence of CaM, this reflects, rather, the inadequacy of the
method for calculating the structure of a short peptide (or
an unfolded protein), which is mostly unfolded, and
probably contains a mixture of transient structures. For
the structure modeling (see below), the peptide was mod-
eled as a helix due to its homology to other (kinase) pep-
tides that always bind CaM in a helical conformation (but
are indeed disordered when not bound).
A thermal scan from +20 to +98°C demonstrated that the
complex as well as CaM is thermally very stable, showing
the presence of folded structure even at temperatures
exceeding +95°C (Figure 2B). A major transition, increas-
ing the denaturation speed, occurs at a temperature of
around +90°C for both samples. This transition is more
pronounced in the absence of the peptide (CaM alone),
which may indicate a stabilising effect by the peptide. Fur-
thermore, cooling the samples back to +20°C in a similar
fashion induced refolding of CaM (Figure 2C), and the
presence of the peptide did not cause significant differ-
ences in the refolding.
Calorimetric binding assay
Isothermal titration calorimetry was used to study the
interaction between the MBP peptide and CaM (Figure 3).
Experiments were done at four different temperatures
(+25, +30, +35, and +40°C), and the calculated thermo-
dynamic parameters are presented in Table 2. The Kd val-
ues obtained were similar at temperatures below +35°C,
and the heat-dependent conformational change of CaM –
most likely slight unfolding of the central linker helix
[27], starting around +35°C, can be seen in the measured
∆H values, that also become unreliable at +40°C while
the affinity is decreased. The binding reaction has favour-
able enthalpy and entropy, being mainly entropically
driven. The favourable entropy is, at least partially, a result
of releasing ordered water into solution from the surfaces
of the binding components.
The binding isotherms were characteristic of a biphasic
binding event, in which first, a high-affinity specific bind-
ing occurs, and in the later stages of titration, a low-affin-
ity nonspecific binding, with a large number of binding
sites and favourable enthalpy, can be detected. The latter
is probably due to electrostatic interactions between the
peptide and CaM, after the single specific binding site is
saturated. The measured dilution heat was basically zero
(Figure 3A), and it was assumed that the titrations will
each time approach zero.
To characterize the binding of the peptide to the specific
binding site of CaM, only the peaks 2–7 were chosen for
curve fitting to model 1:1 binding (Figure 3B). When
using all data (data points 2–20), the best curve fitting
could be obtained by using an artificial model imple-
menting four sequential binding sites (Figure 3C). In both
Table 1: Deconvolution of the CD spectra into secondary 
structure content, using k2d. The results obtained by subtracting 
the CaM and peptide spectra from the complex spectrum are 
shown on the last two rows.
Sample α-Helix β-Sheet Random coil
CaM 0.88 0 0.12
peptide 0.05 0.47 0.48
Complex 0.72 0.03 0.25
Complex-CaM 0.03 0.50 0.47
Complex-peptide 0.72 0.03 0.26
Circular dichroism spectroscopy Figure 2
Circular dichroism spectroscopy. A. CD spectra of the 
CaM-peptide complex (red) and CaM (black). CaM was used 
at 0.050 mg/ml (in both samples) and the peptide at 0.030 
mg/ml. B. Thermal stability curves of CaM (black) and the 
complex (red), monitored at 222 nm. Mean residue ellipticity 
as a function of temperature was measured during heating 
from +20 to +98°C (thick lines). Refolding of the samples 
during cooling from +98 to +20°C is indicated by the thin 
lines.BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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cases, the thermodynamic parameters for the first, high-
affinity, binding event are highly similar (Table 2). This
indicates that accurate values could be obtained for the
high-affinity binding event even in the presence of non-
specific background.
The effect of temperature on the enthalpy of binding,
which can be reliably measured even in the presence of
secondary low-affinity binding sites, is presented in Figure
3D. The enthalpies from the calorimetric studies were
plotted against temperature and the formed slope
(between 25–30°C) represents the heat capacity change
∆Cp upon complex formation. The heat capacity, esti-
mated from the two data points at +25 and +30°C, -0.13
kcal mol-1 K-1 (-0.54 kJ mol-1 K-1), is negative for the com-
plex. It is clear that more assays should be performed to
obtain an accurate value for ∆Cp of the complex.
Isothermal titration calorimetry Figure 3
Isothermal titration calorimetry. A. Titration of the MBP peptide (1 mM) into a solution of CaM (0.1 mM) at +30°C. The 
results of a control reaction, where the MBP peptide was titrated into buffer at +30°C, are indicated above, moved up by 0.1 
µcal/s for clarity. B. Fitting for the specific binding site only. The solid line indicates the non-linear least squares fit for the inte-
grated area under peaks 2–7. The fitting model is one binding site. C. Fitting of all data to a multi-site model. The solid line indi-
cates the non-linear least squares fit for the integrated area under peaks 2–20. The used model is for 4 sequential binding sites. 
Only the parameters for first binding event were used for analysis. D. The observed enthalpy as a function of temperature. The 
heat capacity (∆Cp = -0.13 kcal mol-1 K-1) is the slope calculated by using ∆H values at temperatures +25 and +30°C.BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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Surface plasmon resonance
The interaction of the peptide and CaM was further stud-
ied by real-time biomolecular interaction analysis with
surface plasmon resonance (SPR). The kinetics of the
binding reaction were studied by injecting different con-
centrations of the MBP peptide over an immobilised CaM
surface (Figure 4A). The data confirm the binding of the
MBP peptide by immobilised CaM, and a Kd value of 58
µM can be estimated from the data. The difference in the
Kd values obtained by SPR and ITC may be explained by
the fact that CaM was immobilised on a solid support for
the SPR analysis. The data could only be properly fit by a
conformational change model (A+B <-> AB <-> AB*), in
which, upon initial complex (AB) formation, the confor-
mation of the complex alters (AB*). Even so, it became
clear that the signal for the second conformation (AB*) is
lower than for the first (AB), which significantly compli-
cates the analysis and makes the calculated kon and koff val-
ues (ka1 = 6700 M-1 s-1, kd1 = 0.14 s-1, ka2 = 0.004 s-1, kd2 =
0.011 s-1), especially for the second step of the reaction,
unreliable. It is not possible to take such a situation into
account in the BIAevaluation software, and in order to
obtain a good fit, it was necessary to use additional
parameters to describe the background level. A decrease in
the SPR signal between two conformations has been
observed previously for the binding of small molecules by
a maltose-binding protein [28]. Ligand binding to a recep-
tor that correspondingly decreases in hydrodynamic
radius yielded a negative change in resonance units (RU).
It was also proposed that the sign of the RU change is a
function of the net change in hydrodynamic radius that
occurs upon ligand binding [28]. Since by using the equi-
librium RU values, the obtained Scatchard plot is curved
(not shown), it is possible that similarly to the ITC exper-
iment, the SPR signal is a combination of low- and high-
affinity binding events. A further analysis of the data by
non-linear regression by using a 2-site binding model (in
GraphPad Prism) and the RU values at equilibrium gives
evidence that a low-affinity binding event is seen at high
concentrations of the peptide, and the corresponding Kd
values are approximately 10 and 1000 µM for the two
binding events.
The conformational change model for the interaction was
also suggested by the linked reaction control experiment,
in which the dissociation rates of one analyte concentra-
tion (20 µM) after different injection times were com-
pared (Figure 4B). An increased stability of the complex
with longer injection times can be observed from the fact
that the dissociation rates get slower with increased injec-
Surface plasmon resonance Figure 4
Surface plasmon resonance. A. SPR sensorgrams (black) 
of the binding of the MBP peptide (duplicate assays using 2.5, 
5, 20, 50, 100, and 200 µM) onto immobilized CaM. Data 
were fit to the two-state conformational change model, and 
the resulting fit is shown in red. B. Control experiment for 
linked reactions (heterogeneity test) by SPR. The sensor-
grams have been aligned to the end point of the injection. 
The injection times are as follows: 1 min (magenta), 3 min 
(blue), 20 min (green).
Table 2: Thermodynamic parameters from ITC of the MBP peptide binding to CaM. The shown values are from fitting for the specific 
binding site only. In parentheses, the values for the first binding event are given when fitting is done to a 4-site model.
T Kd (µM) ∆H (kcal/mol) -T ∆S (kcal/mol) n
298.15 K (25°C) 3.4 (1.0) -1.47 ± 0.13 (-1.44 ± 0.04) -6.00 (-6.73) 0.83 ± 0.23 (1)
303.15 K (30°C) 2.3 (1.1) -2.11 ± 0.06 (-2.07 ± 0.02) -5.71 (-6.18) 0.67 ± 0.02 (1)
308.15 K (35°C) 1.9 (1.0) -2.38 ± 0.10 (-2.34 ± 0.03) -5.67 (-6.13) 0.63 ± 0.02 (1)
313.15 K (40°C) 25.9 (1.7) -1.09 ± 0.97 (-0.73 ± 0.05) -5.48 (-7.56) 0.70 ± 0.17 (1)BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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tion time. The experiment clearly showed that longer
injections of the MBP peptide give a more stable CaM-
peptide complex, which also suggests the occurrence of a
conformational change. Furthermore, during longer injec-
tions, the signal decreases already during the injection,
indicating that the signal for the AB* state is indeed lower
than that for the AB state.
Mapping the MBP-binding site of CaM by nuclear 
magnetic resonance (NMR) spectroscopy
NMR spectroscopy was used to identify CaM residues
whose chemical shifts change upon forming the Ca2+/
CaM-MBP peptide complex (Figure 5). To the most part,
these residues are concentrated around the known pep-
tide binding pocket of the CaM C-terminal lobe. Identi-
fied residues in this region include, for example, Leu105,
Arg106, Ala128, Phe141, Gln143, Ala147, and Lys148.
The result that chemical shift perturbations were also
observed for residues in the central helix indicates either
bending of the helix upon peptide binding or a direct
interaction between the peptide and the central helix. The
chemical shift perturbations of some residues, mainly
Phe12 and Lys13, of the N-terminal lobe suggest that the
peptide is not only bound to the C-terminal lobe, but
rather, interacts also weakly with the N-terminal lobe.
Taken together, the NMR data show that the MBP peptide
interacts most significantly with the hydrophobic pocket
in the CaM C-terminal lobe, but also with parts of the cen-
tral helix and the N-terminal lobe. These data were further
used as restraints when building and refining a solution
structure of the complex using small-angle X-ray scattering
(SAXS) (see below).
Solution structure from SAXS
Overall parameters
The experimental scattering patterns from free CaM and
the complex are presented in Figure 6A, and the overall
structural parameters computed from the SAXS data are
given in Table 3. The molecular mass and the volume of
the complex exceed those of free CaM by about 14%. This
increase is fully compatible with that expected (12%)
from the sequences of CaM and the peptide, which proves
the formation of a 1:1 complex. On the other hand, the
maximum diameter of the complex is practically
unchanged, and its radius of gyration is even smaller than
that of free CaM. This suggests that CaM keeps the
extended conformation in the complex and that the pep-
tide is bound to the central part of CaM, rather than to its
periphery. The scattering curve from the atomic model of
CaM was computed by the program CRYSOL [29]. It
agrees reasonably with the experimental data showing
only some minor deviations (Figure 6A, Table 3), which
may be attributed to incompleteness of the crystallo-
graphic model.
Distance distribution functions
The distance distributions p(r) of the two samples com-
puted from the experimental data by the program GNOM
[30] are given in Figure 6B. These functions are similar up
to intraparticle distances of 1.2 nm but display different
profiles at larger distances. The p(r) of free CaM has a
skewed form characteristic for elongated particles, and the
maximum in the p(r) function at about 4 nm, correspond-
ing to the distance between the two lobes of CaM, whereas
the more symmetric p(r) of the complex clearly points to
a more globular shape. Taken together, the comparison of
distance distribution functions also confirms the complex
formation, with the interface at the central part of CaM. A
decrease in CaM length upon peptide binding, as
observed in a number of structures of high-affinity CaM-
peptide complexes [31-33] is not observed. Ab initio
shapes of free and loaded CaM generated by DAMMIN
(not shown) also confirm that there is no significant
change in the maximum dimension of CaM upon peptide
binding.
Shape determination
The ab initio model of the complex highlighting the loca-
tion of the peptide was generated by the multiphase bead
modeling program MONSA [34]. Several independent
runs yielded reproducible results, in which experimental
scattering profiles were neatly fitted (Figure 6A, Table 3).
The models created by MONSA were very similar to those
generated by DAMMIN independently for free and loaded
CaM. This finding supports the assumption that no signif-
icant change of overall shape occurs upon binding and the
use of the two curves for simultaneous fitting by MONSA
is valid. A typical model selected by DAMAVER [35] pre-
sented in Figure 7 yielded an average normalised spatial
discrepancy (NSD) value below 1.0 (see Materials and
Methods). It demonstrates that the peptide is positioned
between the two lobes of CaM, being closer to one of
them. The overall appearance is, thus, in agreement with
the conclusions made from primary data processing.
Molecular modelling
The crystallographic model of CaM is compatible with the
experimental SAXS data from the free protein, and no sig-
nificant compaction of CaM was observed in the complex.
As small conformational changes upon peptide binding
could still not be excluded, we split CaM into three frag-
ments (central helix, N- and C-termini of CaM) for the
molecular modelling of the complex. The peptide was
modelled as a helix for simplicity and due to homology,
but the low resolution of the SAXS data does not allow for
the determination of the exact conformation of the pep-
tide. The program SASREF [36] was employed to construct
a low-resolution 3D model of CaM loaded with the pep-
tide by using distance restraints from NMR data and
requirement of chain compatibility for the three CaM seg-BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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1H-15N HSQC spectra for the titration of CaM with the MBP peptide Figure 5
1H-15N HSQC spectra for the titration of CaM with the MBP peptide. A. Overlay of 1H-15N HSQC spectra of Ca2+/
CaM alone (black) and the Ca2+/CaM-MBP peptide complex (pink; 1:0.333, blue; 1:0.666, red; 1:1). The samples contained 0.5 
mM CaM, 120 mM NaCl, 2.5 mM CaCl2, and 50 mM deuterated Tris-HCl (pH 7.5) in 90% H2O and 10% D2O. Changes in 
cross-peak positions were quantified by [(∆15NHz)2 + (∆1HHz)2]1/2, and some cross-peaks showing larger shifts are indicated on 
the figure. B. Chemical shift perturbations quantified by [(∆15NHz)2 + (∆1HHz)2]1/2. Residues with large perturbations ([(∆15NHz)2 
+ (∆1HHz)2]1/2 > 10.0) are shown. Numbers of each bar show their residual numbers. Positions of four EF hands are also indi-
cated under the graphBMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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ments (see details in Methods). This approach assumes
that the CaM residues with the largest chemical shift per-
turbations in the NMR experiment interact closely with
the peptide, which may not be strictly true for all of them.
A typical rigid body model of the complex generated in
multiple SASREF runs (Figure 7) yields a good fit to the
experimental data of the complex (Figure 6A, Table 3).
The overall shape of CaM in the rigid body modelling
remains similar to that of free CaM. Similarly to the ab ini-
tio modelling results, the results suggest that the peptide is
located between the two lobes, and more specifically, the
tighter contact between the peptide and the C-terminal
lobe observed by NMR is compatible with the SAXS
results. It should be mentioned that at the given resolu-
tion, the models with antiparallel orientations of the pep-
tide-helix are not distinguishable from each other, and
solutions with both peptide directions were obtained,
yielding the same fit to the SAXS data.
Size exclusion chromatography
To further validate the determined solution structure of
the complex, we carried out gel filtration chromatography
and analysed the fractions by SDS-PAGE and silver stain-
ing, allowing the visualisation of both CaM and the pep-
tide (Figure 8). Due to its highly extended conformation,
free CaM routinely runs at an apparent molecular weight
of approximately 30 kDa in gel filtration. A superposition
of the chromatograms (Figure 8A) in the presence and
absence of the peptide indicates that the hydrodynamic
radius of CaM is indeed decreased in the presence of the
peptide. An analysis of the collected fractions clearly
shows that the large, slightly shifted, peak contains both
CaM and the peptide (Figure 8B).
Discussion
Native human brain MBP and a peptide from the MBP C-
terminus bind CaM
An analysis of native human brain MBP indicated that it
interacts directly with CaM in a calcium-dependent man-
ner. A calcium-dependent interaction between human
MBP and CaM has previously been reported for two MBP
charge isoforms isolated from a patient suffering from
multiple sclerosis [20], as have calcium-dependent inter-
actions between bovine and murine MBP and CaM [17-
19].
The human brain MBP sample contained isoforms of 17.2
and 18.5 (predominant) kDa after calmodulin affinity
chromatography. Thus, the regions encoded by neither
exon II (missing in both isoforms) nor exon Vb (missing
in the 17.2-kDa isoform) are required for the interaction.
Only these two major isoforms are expressed in adult
brain [37,38]. The two other major isoforms, 20.2 and
21.5 kDa, are expressed during myelination, as well as
during remyelination in MS lesions [39].
Scattering profiles and distance distribution functions of free  and loaded CaM Figure 6
Scattering profiles and distance distribution func-
tions of free and loaded CaM. A. Scattering data of CaM 
(1, black dots) and the complex (2, blue dots). Dots denote 
the experimental scattering data, the fits obtained by 
MONSA are displayed as red dashed lines, and the fits of the 
crystal structure of CaM and the rigid body model of the 
complex are shown as green solid lines. The plot displays the 
logarithm of the scattering intensity as a function of momen-
tum transfer s = 4π sin(θ)/λ, where 2θ is the scattering angle 
and λ = 0.15 nm is the X-ray wavelength. The curves are 
arbitrarily displaced along the logarithmic axis for better visu-
alization. The insert presents a direct comparison of the 
experimental curves without displacement. B. p(r) functions 
computed from the experimental X-ray scattering patterns 
using the program GNOM. The functions are presented in 
arbitrary units; the colouring scheme is the same that as used 
for the experimental data in (A).BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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A CaM-binding site of MBP has been localised to the C-
terminal region, but so far, a detailed mapping has been
lacking [20,21]. By the use of various bioinformatics
methods and sequence comparisons to known CaM lig-
ands, we were able to design a 19-residue peptide based
on the sequence of human MBP that binds to CaM with
micromolar affinity. The measured affinity for the peptide
towards CaM was similar or slightly weaker than observed
previously for full-length MBP and a C-terminal proteo-
lytic fragment thereof [18,21]. Although the observed
affinity, in the low micromolar range, is lower than for
some other CaM targets, it suggests a physiological rele-
vance for the interaction, taking into account the follow-
ing points: Firstly, the concentration of MBP in myelin is
very high, and the concentration of CaM in cells is also in
the order of 1–10 µM [40], even higher in the nervous sys-
tem [41]. Thus, the measured affinity is in the range that
can regulate the interactions between these two highly
abundant proteins. Secondly, it is likely that the surround-
ing regions of MBP, being highly positively charged, can
interact with and possibly even wrap around CaM, once
the specific recognition of the binding site has occurred;
this would be expected to increase the affinity for complex
formation. Furthermore, the presence of more than one
binding site for CaM in MBP raises the possibility of so-
called allovalency [42], effectively increasing the affinity.
It should be noted that in other vertebrate species, inser-
tions of 1–2 residues are seen near the middle of the pep-
tide that was used (see Methods). This implies either that
there may be subtle species-specific differences in the
interaction between CaM and this MBP segment, or that
the entire length of the peptide is not necessary for the
interaction. For example, it is possible that only one half
of the used MBP peptide is in close contact with the C-ter-
minal lobe of CaM; high-resolution structural data would
be required to fully address this issue.
The region, from which the peptide was selected, is also a
target for MBP posttranslational modifications. Ser151
can be phosphorylated [43] and Gln147 deamidated [44].
Both of these modifications will add a negative charge to
the corresponding position, thus likely decreasing the
affinity for CaM. No citrullination sites are present in the
peptide, however, due to the lack of arginine residues. On
both sides of the used peptide, the MBP sequence does
harbour characterised citrullination sites [45], which
could, in principle, also regulate binding to CaM.
Energetics of the CaM-MBP peptide interaction
The heat capacities of several CaM-associated reactions
have been reported and discussed earlier [46]. Tempera-
tures below +30°C have been systematically used for ITC
binding studies with CaM and CaM-binding peptides.
This is important in order to prevent temperature-induced
conformational changes in CaM [27,47]; this effect is also
seen in our data, making measurements at high tempera-
tures unreliable. CaM-binding peptides have been
Ab initio and rigid body models of the complex Figure 7
Ab initio and rigid body models of the complex. Left 
panel: two-component shape of the complex generated by 
MONSA; Right panel: the rigid body model built by SASREF. 
The peptide parts are given in red. The central helix and the 
N- and C-terminal lobes of CaM in the rigid body model are 
shown in green, yellow, and blue, respectively. The handed-
ness of the ab initio MONSA model was chosen that provides 
the best agreement (lowest NSD) with the rigid body model.
Table 3: Structural parameters defined from the experimental SAXS data. I0, Rg, Vp and Dmax are, respectively, the forward scattering, 
radius of gyration, excluded volume and maximum size calculated from the scattering data. χs and χrb are discrepancies between the 
experimental data and computed scattering curves from typical ab initio and rigid body models (crystallographic model in case of free 
calmodulin).
Sample I0, relative Rg, nm Vp, nm3 Dmax, nm χs χrb
Calmodulin 95.0 ± 5 2.22 ± 0.05 34 ± 2 7.0 ± 0.5 0.8 2.4
Calmodulin+peptide 108.0 ± 3 2.08 ± 0.05 39 ± 2 7.0 ± 0.5 0.8 1.1
Ratio 1.14 0.94 1.15 1.0 - -BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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roughly divided into two groups depending on the heat
capacity upon their complex formation with CaM [46].
CaM-dependent protein kinase I, constitutive cerebellar
nitric-oxide synthase, and melittin peptides have ∆Cp val-
ues around -0.8 kcal mol-1 K-1, which reflects their prefer-
ence for the formation of a globular CaM-peptide
complex. The second group, having a ∆Cp of -0.4 kcal mol-
1 K-1, is composed of phosphodiesterase, the C-terminal
fragment of melittin, and chicken gizzard caldesmon pep-
tides, which interact mainly with one lobe of CaM [46]. In
our current study, the estimated ∆Cp of the formed com-
plex is -0.13 kcal mol-1 K-1, which is different from the
above cases and can indicate different type of binding
compared to the two previously discussed groups of pep-
tides. In fact, it directly suggests a smaller buried surface
area than in the other CaM-peptide complexes – an idea
which is indeed confirmed by our NMR and SAXS studies.
The structure of the CaM-MBP peptide complex in 
solution
SPR indicated that the complex formed between immobi-
lised CaM and the MBP peptide underwent a conforma-
tional change upon binding. A conformational change
was also detected by SPR when the complex between CaM
and the ERR3 receptor was studied [48]. A negative change
in RU, as observed here for the CaM-MBP complex, during
the injection may reflect a decrease in the hydrodynamic
radius of the forming complex [28]. This is also in line
with our results from gel filtration chromatography, in
which the apparent size of CaM is decreased in the pres-
ence of the peptide, indicating a smaller hydrodynamic
radius for the complex than for unliganded CaM. On the
other hand, as expected, CD spectroscopy clearly indi-
cated that no large-scale changes in secondary structure
content occur upon binding.
The solution structure of the CaM-MBP peptide complex
obtained with SAXS is compatible with all of the other
experiments we carried out on the complex. In essence,
the SAXS results indicate that the maximum diameter of
CaM does not change when bound to the MBP peptide,
and the radius of gyration for the complex is slightly
smaller than that of free CaM. This result is fully compat-
ible with the result from gel filtration chromatography.
The peptide can be seen bound to a groove in the central
region of CaM (slightly closer to the C-terminal lobe),
which remains in the extended conformation. In other
words, CaM does not collapse around the MBP peptide, as
seen in several other instances of CaM-peptide recogni-
tion [31-33].
It is possible that the CaM-MBP peptide complex has sev-
eral conformations in solution; however, the fact that
both the ab initio and rigid body models from SAXS fit the
measured data well (Figure 6) indicates that it is likely that
only one major conformation is present, at the resolution
that has been used in the current study. This is also sup-
ported by gel filtration chromatography (Figure 8), where
significantly different conformations of the complex
could yield different peaks or peaks with non-symmetric
Gel filtration of CaM in the presence and absence of the MBP  peptide Figure 8
Gel filtration of CaM in the presence and absence of 
the MBP peptide. A. The elution profiles of CaM (black) 
and the complex of CaM and peptide (red) from a Superdex 
75 column. The arrows above indicate the elution volumes 
and molecular weights (in kDa) of the standard proteins used 
to calibrate the column. The positions of the collected frac-
tions from the complex sample are indicated below the 
graph. The absorbances have been multiplied by 1000 for 
clarity. B. Electrophoretic analysis of the fractions obtained 
from the complex sample on a 16.5-% Tris-tricine peptide 
gel. The samples are as follows: 1, the CaM-peptide mixture 
injected into the column; 2, fraction 10; 3, fraction 11; 4, frac-
tion 12; 5, CaM; 6, peptide. The positions of molecular 
weight markers (in kDa) are indicated on the left, and the 
positions of CaM and the peptide are indicated on right. 
Note how the peak fraction (lane 3) contains both CaM and 
the peptide. A weak low-molecular-weight shadow is also 
seen in the CaM sample (lane 5), but the peptide stains 
intensely dark with silver and can unequivocally be detected 
based on its colour. The faint band above CaM is most likely 
another conformation of CaM.BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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shapes, since the starting point is CaM, an elongated
dumbbell-shaped molecule.
Our NMR data indicate that although the main binding
site for the MBP peptide resides in the C-terminal lobe of
CaM, also the central helix and the N-terminal lobe inter-
act with the peptide. Comparing the structures of our
model and free CaM, the NMR data suggest that a rotation
of the C-terminal lobe takes place upon binding, such that
its hydrophobic pocket interacts closely with the peptide
(Figure 9, Additional file 2). Furthermore, it should be
noted that molecular modelling was used in an earlier
study to predict the modes and energetics of binding of
different short MBP peptides to CaM, including one over-
lapping with the peptide used in this study [22]. As a start-
ing point in these simulations, the fully collapsed CaM
structure from a kinase peptide complex was used. Our
results indicate that this may have been an oversimplifica-
tion, and that the conformation of CaM may be signifi-
cantly different in the CaM-MBP complex.
For CaM-dependent protein kinases, it has been suggested
that studies on CaM-binding peptides accurately reflect
the interactions between CaM and the kinase [49]. It is
possible that for MBP, regions outside the peptide studied
here also participate in complex formation, possibly alter-
ing the affinity and/or conformation of the complex, as
has been observed for the deiminated form of MBP [20].
Interestingly, it has also been suggested that CaM might
be able to bind two molecules of MBP simultaneously in
a cooperative fashion, where both lobes of CaM would
mainly interact with one MBP molecule [19]. Thus, the
structure of the complex determined here may also repre-
sent an intermediate in the binding of full-length MBP by
CaM.
Conclusion
Structural knowledge about myelin proteins in general is
underrepresented in current databases [50,51], despite the
presence of a well-characterised but relatively small set of
specific proteins in the myelin sheath. We have carried out
a detailed analysis of the interaction between CaM and a
19-mer peptide from the C-terminal region of human
MBP, a major protein in the myelin sheath. MBP has been
characterised as being intrinsically unstructured by nature
[3]; however, it presents a multitude of post-translational
modifications and binding partners, which, in turn, affect
its functions in e.g. signaling and regulating the cytoskele-
ton [2]. We have shown that the complex formed between
CaM and the MBP peptide does not collapse, although a
conformational change takes place on a smaller scale, the
main binding site for the MBP peptide residing in the
Mapping of the binding site of the human MBP peptide in CaM to the C-terminal lobe. It should be noted that the structures  shown are extrapolations from the low-resolution SAXS model obtained by rigid-body fitting, as described in Methods Figure 9
Mapping of the binding site of the human MBP peptide in CaM to the C-terminal lobe. It should be noted that 
the structures shown are extrapolations from the low-resolution SAXS model obtained by rigid-body fitting, 
as described in Methods. A. CaM (magenta) and the peptide (green) are shown as ribbons, and the interacting residues, 
based on the NMR experiment, are shown in stick mode with yellow colour. Note how the binding site is localised mainly to 
the hydrophobic pocket of the C-terminal (lower) lobe. B. Stereo view of the conformation of the CaM C-terminal lobe in free 
CaM (pink) and in the SAXS model of the complex (light blue). The peptide is shown in yellow, and superposition has been 
done using the residues of the central helix (pointing towards top right). The N-terminal lobe is omitted from the figure for 
clarity. An animation of the predicted movement is shown in Additional file 2.BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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hydrophobic pocket of the C-terminal lobe of CaM. With
relatively weak binding, such as that observed between
MBP and CaM, a massive conformational change may
indeed not be required, and the binding affinity may be
low in order to maintain the possibility of regulation,
because the concentrations of both interaction partners in
the cell are high. Thus, MBP is another CaM target that
cannot be thought of as being analogous to CaM kinases
with respect to the mode of CaM binding [52]. Our results
provide an important structural insight into the factors
that may regulate myelin formation and maintenance and




A number of sequence analysis tools were applied in order
to be able to select a suitable CaM-binding peptide from
the C-terminal region of human MBP that has been sug-
gested to carry a CaM-binding site [20,21]. Disorder pre-
dictions were carried out using DISembl [53,54],
GlobPlot [55,56], and DRIP-PRED [57]. Secondary struc-
ture predictions were done using the consensus method at
the NPSA [58,59]. Putative functionally flexible regions
were analysed with Wiggle [60]. The CaM target database
[25,61] was searched for putative CaM-binding segments
within MBP, and in the end, the chosen region was man-
ually aligned with CaM-binding regions from CaM-
dependent protein kinases. It should be noted that this
method is unlikely to detect previously uncharacterised
CaM-binding sites.
Materials
The MBP peptide chosen for the present study,
HKGFKGVDAQGTLSKIFKL, corresponding to residues
138–156 of the human MBP 18.5 kDa isoform, of 95%
purity, was obtained from Genemed Synthesis. It should
be noted that some other vertebrates have 1- or 2-residue
insertions in this region, at position 145. The peptide was
dissolved in 50 mM HEPES pH 7.5, 20 mM CaCl2 and
stored at -20°C. The preparation of the CaM expression
construct pETCM, containing vertebrate CaM cDNA, has
been described earlier [62]. Native MBP protein isolated
using the chloroform extraction method [63] from post-
mortem human brain was obtained from FermLab
(Turku, Finland).
Protein purification
CaM was purified using calcium-dependent phenyl sepha-
rose affinity chromatography [62,64]. pETCM was trans-
formed into E. coli Rosetta (DE3), and one colony was
transferred into 10 ml of LB containing 100 µg/ml of amp-
icillin and grown for 7 h at +37°C. For expression, 1 l of
LB medium containing ampicillin (100 µg/ml) was inoc-
ulated with the 10 ml culture. Induction was performed
after 5 h with 0.4 mM IPTG. The culture was further grown
for 12 h, and the cells were harvested by centrifugation.
For stable isotope labeling, modified M9 medium [65]
was used instead of the LB medium. The cells were sus-
pended in 50 ml of cold lysis buffer (10 mM HEPES pH
7.5, 1 mM EDTA, 1 mM NaN3, 10 mM DTT, 10 µg/ml
DNAse I), and lysozyme and RNAse A were added to 100
µg/ml and 2 µg/ml, respectively. Cell suspensions were
stored at -80°C until needed. Cells were disrupted by son-
ication. After centrifugation (27000 g, 20 min), the super-
natant was heated in a +80°C water bath for 10 min and
centrifuged (27000 g, 20 min). 5 mM CaCl2 were added to
the supernatant, and the sample was centrifuged once
more.
The soluble proteins were applied to a phenyl sepharose
column (Pharmacia Biotech Inc), equilibrated with 10
mM HEPES pH 7.5, 4 mM CaCl2. The column was consec-
utively washed with excess equilibration buffer, equilibra-
tion buffer supplemented with 500 mM NaCl, and
equilibration buffer again. Elution of CaM was then car-
ried out with 10 mM HEPES pH 7.5, 5 mM EGTA. The
fractions were analyzed by SDS-PAGE, and the fractions
containing CaM were pooled and concentrated by centrif-
ugal ultrafiltration.
Affinity chromatography of human brain MBP on CaM-
sepharose
Calcium-dependent affinity chromatography of human
MBP on CaM-sepharose (GE Healthcare) was carried out
as follows: 200 µg of lyophilized human brain MBP were
dissolved in 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM
CaCl2. The same buffer that was used to equilibrate 100 µl
of the CaM-sepharose matrix. The sample was mixed with
the matrix and washed with 5 ml of the above buffer. Elu-
tion was done with 1.4 ml of 50 mM HEPES pH 7.5, 150
mM NaCl, 2 mM EGTA. The fractions were applied on a
18% SDS-PAGE gel. To detect which isoforms were bound
to CaM-sepharose, fractions 2 (wash) and 7 (EGTA elu-
tion) were purified with Vivapure® C18 Micro spin col-
umns prior to analysis by mass spectrometry. MALDI-ToF
mass spectrometry was performed with a Voyager-DE STR
Biospectrometry Workstation (Applied Biosystems). 1 µl
of the protein sample was spotted on sinapinic acid
matrix.
Circular dichroism spectroscopy
Far-UV CD spectra in the 196–250 nm region were
recorded at +20°C with a JASCO J-715 CD-spectropola-
rimeter (Jasco Corp., Tokyo, Japan), using a 1-mm path
length quartz cell. The spectra were corrected by subtract-
ing the spectrum of a buffer sample (10 mM HEPES pH
7.5, 150 mM NaCl, 4 mM CaCl2). Noise reduction was
applied to smooth the data with the Jasco software. The
spectra are presented as mean residue ellipticity (θ), calcu-BMC Structural Biology 2008, 8:10 http://www.biomedcentral.com/1472-6807/8/10
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lated by using the molar concentration of peptide or pro-
tein and multiplying by the appropriate number of
peptide bonds. CaM concentration in the sample was
0.050 mg/ml and the peptide concentration was 0.030
mg/ml. Secondary structure contents of the samples were
estimated with the program k2d [26].
Thermal denaturation of CaM in the presence and absence
of the MBP peptide was followed by monitoring the ellip-
ticity at a fixed wavelength of 222 nm while the sample
was heated at a rate of 30°C/h from +20 to +98°C. Free
CaM concentration in the sample was 0.15 mg/ml and in
the CaM/peptide mixture, the concentrations of CaM and
the peptide were 0.20 and 0.30 mg/ml, respectively. A
cooling experiment to monitor putative refolding of the
protein was also similarly done for the same samples from
+98 to +20°C at a rate of 30°C/h
Isothermal titration calorimetry
The binding of the MBP peptide to CaM was studied by
ITC, using a VP-ITC microcalorimeter (MicroCal,
Norhampton, MA). The samples for the experiment were
extensively dialysed against 50 mM HEPES pH 7.5, 20
mM CaCl2 and degassed in an ultrasonic water bath. The
MBP peptide solution (1.0 mM) was injected into the
sample cell, containing 0.10 mM CaM in the above buffer.
The first injection of 2 µl was followed by 19 15-µl injec-
tions of the peptide. The experiment was carried out at
+25, +30, +35, and +40°C. The dilution heat was meas-
ured by titrating the buffer with the 1 mM peptide solu-
tion. The heat of dilution was practically zero. The raw
data were fitted by non-linear least squares minimisation
with models for both a single site and four binding sites
(see Results), using the Origin version 5.0 software
(MicroCal).
Surface plasmon resonance
SPR assays were performed with a Biacore 3000 instru-
ment (Biacore AB, Uppsala, Sweden). CaM was immobi-
lized covalently on a hydrophilic carboxymethylated
dextran matrix sensor chip (Biacore AB), with standard
amine coupling chemistry [66] at pH 3.8, at a level of
4000 RU. Binding of the peptide was tested in 10 mM
HEPES pH 7.5, 150 mM NaCl, 4 mM CaCl2 containing
0.005% P-20 surfactant (Biacore AB), at a flow rate of 30
µl/min. Various concentrations of the peptide (2.5–200
µM) were injected in duplicate over both of the flow cells
for 3 min, and a 6-min dissociation phase followed each
injection. The surfaces were regenerated with a 20-s injec-
tion of 10 mM EDTA and another 10-s injection of 20 mM
NaOH at a flow rate of 30 µl/min prior to the next injec-
tion cycle. The BIAevaluation software version 3.1
(Biacore AB) was used to analyse the data. Bulk effects
were subtracted using a reference surface without CaM.
Furthermore, a sensorgram of the injection of buffer alone
was subtracted from the data. The data were analysed
using the various interaction models available in the soft-
ware, including the mass transfer model. The only model
giving a reasonable fit to the data was the conformational
change model (see Results).
A control experiment for linked reactions ("heterogeneity
test") for the binding reaction was used to analyse the sta-
bility of the forming complex as a function of injection
time. A 20-µM solution of the peptide in the running
buffer was injected over the flow cells of the CaM-coated
sensor chip at a flow rate of 30 µl/min, using different
injection times (1, 3, and 20 min). Each injection was fol-
lowed by a 15-min dissociation time. The surface was
regenerated and the data were treated as above.
Small-angle X-ray scattering
SAXS data collection and processing
Synchrotron X-ray scattering data from solutions of cal-
modulin in the presence and absence of the MBP peptide
were collected at the X33 beamline (DESY, Hamburg)
using a MAR345 image plate detector. The scattering pat-
terns of both samples were measured at several solute con-
centrations c, ranging from 5.4 to 140.0 mg/ml, and in the
complex samples, a 5-fold molar excess of the peptide was
always present. For the complex, it was calculated, based
on the determined Kd from calorimetry, that more than
99.8% of total CaM was expected to be in the complex
state even at the lowest used concentration. At a sample-
detector distance of 2.7 m, the range of momentum trans-
fer 0.1 <s < 5 nm-1 was covered (s = 4π sin(θ)/λ where 2θ
is the scattering angle and λ = 0.15 nm is the X-ray wave-
length). The data were processed using standard proce-
dures by the program package PRIMUS [67]. The forward
scattering I(0) and the radii of gyration Rg were evaluated
using the Guinier approximation [68], assuming that at
very small angles (s < 1.3/Rg), the intensity is represented
as I(s) = I(0) exp(-(sRg)2/3). The maximum dimensions
Dmax were computed using the indirect transform package
GNOM [30], which also provides the distance distribu-
tion functions p(r).
The increase in the molecular mass (MM) of CaM upon
peptide binding was verified by the analysis of the forward
scattering value I(0) using the proportion MM ~ I(0)/c. In
addition, the excluded (Porod) volumes Vp of the solutes
were also analyzed, calculated as [69]:
In this calculation, an appropriate constant was sub-
tracted from each data point to force the s-4 decay of the
intensity at higher angles following Porod's law [69] for
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homogeneous particles. For globular proteins, Porod (i.e.
hydrated) volumes in nm3 are approximately twice the
MMs in kDa.
Ab initio shape determination
Low resolution ab initio shapes of free and loaded CaM
were first reconstructed independently using the program
DAMMIN [34]. In a more versatile approach, the ab initio
model of the complex was constructed by simultaneous
fitting of the scattering from free and loaded CaM by a
two-component model using the program MONSA
[34,70]. The program represents the particle as a collec-
tion of M >> 1 densely packed beads inside a sphere with
the diameter Dmax. To describe the overall and internal
structure of the complex particle, each bead can be
assigned either to the solvent (index = 0) or to one of the
components (in our case, index = 1 corresponds to CaM
and index = 2 to the MBP peptide). The complex between
CaM and the peptide is therefore represented at low reso-
lution by two "phases", and the structure is described by a
string of length M, containing the phase index for each
bead (0, 1, or 2). Simulated annealing (SA) [71-73] is
employed to search starting from a random string for a
model composed by interconnected compact phases,
which simultaneously fits the shape scattering curves from
free CaM and the complex (Ik(s), k = 1, 2) to minimize
overall discrepancy:
where the index k runs over the scattering curves, Nk are
the numbers of experimental points, ck are scaling factors,
and Icalc(s) and σ(sj) are the intensities calculated from the
subsets of the beads, belonging to the appropriate phases
and the experimental errors at the momentum transfer sj,
respectively.
Molecular modelling
SASREF [36] was employed for molecular modelling of
the complex, using the available atomic model of verte-
brate calcium-loaded CaM (PDB entry 1UP5) [74]. SAS-
REF employs SA to minimize the target function F in a
form:
where the first term ensures minimization of the overall
discrepancy and the set of penalties Pi with their weights
αi formulates various requirements and restrictions to the
model (e.g. interconnectivity, contacts absence of over-
laps) [36]. The penalty weights for disconnectivity and
distance restraints had the default values of 10. The weight
of the overlap penalty was increased (to 100), as the
resulting models tend to have some clashes while using
the default weight.
The peptide was modelled by modifying the sequence of
the homologous peptide from human DRP-1 kinase, as
present in the corresponding CaM-peptide complex (PDB
entry 1WRZ). To account for possible conformational
changes upon peptide binding, CaM was represented by
three rigid bodies, namely by the N-terminal lobe, the
central helix, and the C-terminal lobe (residues 4–64, 65–
93, and 94–148, respectively). SASREF positions the four
rigid bodies (three CaM portions and the peptide) with
respect to each other using SA to form an interconnected
assembly without steric clashes, while minimising the dis-
crepancy between the experimental data and the scatter-
ing profile from the model of the complex. The latter is
calculated based on the pre-computed scattering ampli-
tudes of the subunits in the reference positions and orien-
tations. Scattering from the atomic models was calculated
using the program CRYSOL [29]. SASREF allows one to
account for contacts between specific residues in the sub-
units using distance restraints. In the present work, the
polypeptide chain compatibility of the entire CaM was
ensured by restraining the distances between appropriate
terminal residues of three CaM portions to 0.4 nm. More-
over, the information on chemical shift perturbations
from the NMR experiment (see NMR section) was also
included into SAXS-based molecular modelling by adding
the proximity requirement between the peptide and the
CaM residues that were observed to be involved in bind-
ing the MBP peptide. In brief, a distance restraint of 10 Å
was used between the peptide and residues 78, 80, 85, or
88 of CaM. A restraint of 7 Å was imposed on the distance
between the peptide and CaM residues 130, 137, or 141
and between the peptide and CaM residues 143 or 147.
The restraint terms were not adjusted during minimisa-
tion. A discussion on the shape of the restraint functions
has been previously published [36].
For the ab initio and rigid body analyses, multiple runs
were performed to verify the stability of the solution, and
typical 3D reconstructions are presented in the results sec-
tion. The models generated in 10 independent runs
yielded an averaged NSD value of about 1.0 according to
the automated superposition program SUPCOMB [75].
Such an NSD value means that the models are indistin-
guishable at the resolution provided by SAXS. The analysis
of common structural features of the models was done
using the programs DAMAVER [35] and SUPCOMB. The
latter program aligns two arbitrary low or high resolution
models represented by ensembles of points by minimiz-
ing a dissimilarity measure, NSD. For every point (bead or
atom) in the first model, the minimum value among the
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model is found, and the same is done for the points in the
second model. These distances are added and normalized
against the average distances between the neighboring
points for the two models. Generally, NSD values close to
unity indicate that the two models are similar. The pro-
gram DAMAVER specifies the most typical model (i.e. that
having the lowest average NSD with all the other models
of the set of superimposed structures).
The rigid body model and the original data are included
in this paper as Additional files 3 and 4, respectively.
Size exclusion chromatography
Gel filtration chromatography with the ÄKTApurifier sys-
tem (Pharmacia Biotech) was used to investigate the dif-
ference in the behaviour of CaM in the presence and
absence of the MBP peptide. A Superdex 75 HR 10/30 col-
umn (Amersham Pharmacia Biotech) was equilibrated
with 50 mM HEPES buffer pH 7.5, 150 mM NaCl, 4 mM
CaCl2. The experiments were run at a flow rate of 0.5 ml/
min, the injection volumes were 250 µl, the concentration
of CaM was 0.8 mM, and the concentration of the peptide
was 4 mM. SDS-PAGE on a 16.5% Tris-tricine gel (Bio-
Rad) combined with silver staining [76] was used to visu-
alise the peptide and CaM from the fractions.
Nuclear magnetic resonance spectroscopy
All NMR experiments were carried out on a Bruker DMX-
500 spectrometer using a 5-mm broadband, z-axis gradi-
ent-shielded probe at 298K. Two-dimensional 1H-15N
HSQC spectra were obtained by pulse field gradient selec-
tion [77]. The sweep width was 12 ppm in the 1H dimen-
sion and 30 ppm in the 15N dimension, with the 1H
carrier set at 500.1324 MHz and the 15N carrier at 50.6814
MHz. The size of the HSQC spectra was a 1024 × 1024 real
data matrix with eight scans for each experiment. Proton
chemical shifts were referenced to 2,2-dimethyl-2-silapen-
tane-5-sulfonate as 0 ppm. Nitrogen-15 chemical shifts
were referenced to liquid NH3.
The sequential assignments for the backbone nuclei of the
15N/13C-labeled Ca2+/CaM were mainly achieved by a set
of experiments, CBCA(CO)NNH, CBCANNH, HNCO,
and HN(CA)CO. Sidechain assignments were obtained
using HBHA(CO)NNH, H(CCCO)NNH, CC(CO)NNH,
and HCCH-TOCSY experiments. The assignments for the
protein backbone nuclei of the 15N-labeled Ca2+/CaM –
MBP peptide complex were achieved by the two-dimen-
sional  1H-15N HSQC spectral changes induced by titra-
tions of myelin peptide to the Ca2+/CaM. NMR spectra
were processed on a Silicon Graphics O2 workstation
using Bruker XWIN-NMR and Accelrys Felix 2000 soft-
ware packages.
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